Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Hydroxychloroquine + Gemcitabine in Pancreatic Cancer
NCT01128296Phase 2Completed
- Start
- Oct 2010
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in pancreatic adenocarcinoma (PDAC). Started Oct 2010; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01128296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01128296.